Clinical trials on medical products for human use in the case of acutely incapacitated patients within the fields of neurology and neurosurgery; implications of the new European legislation;Klinisch geneesmiddelenonderzoek bij acuut beslissingsonbekwame patiënten in de neurologie en de neurochirurgie; implicaties van nieuwe Europese regelgeving

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 33, 2003, Pages 1585-1589

  Kompanje, E J O ^a   Maas, A I R ^a   Dippel, D W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

BRAIN INFARCTION; BRAIN INJURY; CLINICAL TRIAL; ETHICS; EUROPE; INFORMED CONSENT; LAW; MEDICAL RESEARCH; NEUROLOGY; NEUROSURGERY; PROTECTION; REVIEW; SAFETY;

CLINICAL TRIALS, PHASE III; ETHICS COMMITTEES, RESEARCH; ETHICS, RESEARCH; EUROPEAN UNION; HUMANS; NETHERLANDS; SAFETY; THERAPEUTIC HUMAN EXPERIMENTATION; THIRD-PARTY CONSENT; TREATMENT OUTCOME;

EID: 0042825896     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. European Committee. European directive on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use (Directive 2001/20/EC). Off J Eur Comm 2001;L121:34-44.
2. Cohen AF. Europese richtlijn voor de kwaliteit van niet-commerciële klinische trials: elegante implementatie voor Nederland via de gewijzigde Wet Medisch-wetenschappelijk Onderzoek met Mensen. Ned Tijdschr Geneeskd 2003;147:1493-5.
3. Mason SA, Allmark PJ. Obtaining informed consent to neonatal randomised controlled trials: interviews with parents and clinicians in the Euricon study. Lancet 2000;356:2045-51.
4. US Food and Drug Administration. Code of federal regulations. Title 21. Part 50. Section 50.24. Exception from consent requirements for emergency research. New York: US Food and Drug Administration; 1996.
5. Freeman BD, Danner RL, Banks SM, Natanson C. Safeguarding patients in clinical trials with high mortality rates. Am J Respir Crit Care Med 2001;164:190-2.
6. Maas AIR, Steyerberg EW, Murray GD, Bullock R, Baethmann A, Marshall LF, et al. Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations. Neurosurgery 1999;44:1286-98.
7. Gladstone DJ, Black SE, Hakim AM. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery. Stroke 2002;33:2123-36.
8. Visser HKA. Non-therapeutic research in the EU in adults incapable of giving consent? Lancet 2001;357:818-9.
9. Visser HKA. Europese regelgeving voor klinisch geneesmiddelenonderzoek bij minderjarigen en meerderjarige wilsonbekwamen. Ned Tijdschr Geneeskd 2001;145:942-5.
10. Singer EA, Müllner M. Implications of the EU directive on clinical trials for emergency medicine. BMJ 2002;324:1169-70.
11. Lemaire F, Baeyens AJ. Clinical research: a European Union directive. Intensive Care Med 2002;28:660.
12. Lemaire F. European Society of Intensive Care Medicine statement. Clinical research in intensive care unit. European Society of Intensive Care/Medicine. Intensive Care Med 2002;28:1218-9.
13. Sterz F, Singer EA, Böttiger B, Chamberlain D, Baskett P, Bossaert L, et al. A serious threat to evidence based resuscitation within the European Union. Resuscitation 2002;53:237-8.
14. Plomer A. Protecting the rights of human subjects in emergency research. Eur J Health Law 2002;8:333-52.
15. Dirks B. The right to informed consent or the right to life. Resuscitation 2002;53:241.
16. Herlitz J. Consent for research in emergency situations. Resuscitation 2002;53:239.
17. Safar P. Clinical resuscitation research and informed consent. Resuscitation 2002;54:311-2.
18. Stocchetti N, Dearden M, Karimi A, Lapierre F, Maas A, Murray GD, et al. New European directive on clinical trials. Lancet 2003;361;1473.